What kind of test is MySignal?

MySignal is a test that analyzes microRNA in urine using AI to assess the risk of 10 types of cancer from Stage 1. It can be taken without physical burden.

Why is it being publicly funded in Misato Town?

Misato Town faces challenges with a high aging rate and low cancer screening rates. The aim is to achieve early cancer detection in regions with difficult access to medical care.

Who is eligible for the MySignal test?

100 residents of Misato Town aged 40-74 who undergo a specific health checkup in fiscal year 2026 will be selected by lottery.

AI News NQ Analysis

Craif Launches MySignal with First-Ever Public Funding by a Local Government Nationwide

NQ Score 50/100

AI Summary (NQ-processed)

Craif Inc. partners with Misato Town, Shimane Prefecture, to introduce MySignal, a urine-based cancer screening, with public funding, aiming for early cancer detection beyond healthcare access barriers.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What kind of test is MySignal?: A: MySignal is a test that analyzes microRNA in urine using AI to assess the risk of 10 types of cancer from Stage 1. It can be taken without physical burden.
Q: Why is it being publicly funded in Misato Town?: A: Misato Town faces challenges with a high aging rate and low cancer screening rates. The aim is to achieve early cancer detection in regions with difficult access to medical care.
Q: Who is eligible for the MySignal test?: A: 100 residents of Misato Town aged 40-74 who undergo a specific health checkup in fiscal year 2026 will be selected by lottery.